FLT1 and neoplasm: The predictive power of the FFL (PDGF/FLT1/SHC1) in the PIK3CA-mutated luminal-A tumor patients demonstrated in this study could be further validated in other breast cancer cohorts when genome sequencing data for these cohorts are available in the future.